Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teyro Labs
Chennai, Tamil Nadu, Indiateyro.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Teyro Labs manufactures and supplies generic finished dosage formulations and APIs with a focus on oncology and high-potency sterile/non-sterile products. They operate cGMP-compliant R&D and manufacturing facilities; sample portfolio includes commercial products like capecitabine, carboplatin, imatinib, sunitinib. The company is approved by key agencies (US FDA) and supplies globally[1][2][3][4].
- Therapeutic areas
- OncologyEndocrinologyOther
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
Out-licensing and CDMO/CMO partnerships (exact names not specified)[3]
Beyond the preview
Go deeper on Teyro Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Teyro Labs.